Literature DB >> 12904992

Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.

Yoshinobu Wakisaka1, Akiko Furuta, Yumihiro Tanizaki, Yutaka Kiyohara, Mitsuo Iida, Toru Iwaki.   

Abstract

In dementia with Lewy bodies (DLB), the Lewy bodies (LBs) are an essential substrate. Although LB pathology has gained increasing attention as one of the major causes of dementia, little is known about the exact prevalence of LB pathology in the general population. In addition, the pathology of Alzheimer-type dementia (ATD) is frequently associated with DLB. To investigate the prevalence of LB pathology in a community-based population and to evaluate the relationship between LB and ATD pathology, we performed an analysis of 102 consecutive autopsy cases. The survey extended over 2.5 years and autopsy rate was 70.5%. LB pathology was detected using alpha-synuclein immunohistochemistry and was assessed based on consensus guidelines for DLB. ATD pathology was evaluated by both CERAD and NIA-RI criteria. Twenty-nine subjects were clinically demented. LB pathology was present in 23 (22.5%) of 102 cases, and in 12 (41.4%) of the demented subjects. The LB score was not significantly different between DLB cases and non-demented subjects with LB pathology (nd-LB), while the Braak stages were significantly different between the two groups. Prevalence of LB pathology constantly increased with age. DLB cases accompanying severe ATD pathology showed more rapid increase of LB scores than did DLB cases without severe ATD pathology. Moreover, DLB cases with severe ATD pathology had poorer prognoses than those without severe ATD pathology. Our results suggested that aging and severe ATD pathology have a strong effect on the evolution of LB pathology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904992     DOI: 10.1007/s00401-003-0750-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  37 in total

1.  Spinal cord involvement in Lewy body-related α-synucleinopathies.

Authors:  Raffaele Nardone; Yvonne Höller; Francesco Brigo; Viviana Versace; Luca Sebastianelli; Cristina Florea; Kerstin Schwenker; Stefan Golaszewski; Leopold Saltuari; Eugen Trinka
Journal:  J Spinal Cord Med       Date:  2019-01-08       Impact factor: 1.985

Review 2.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

3.  Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but 'failure to fit' is highly dependent on staging system applied.

Authors:  David G Coughlin; Helen Petrovitch; Lon R White; Joseph Noorigian; Kamal H Masaki; G Webster Ross; John E Duda
Journal:  Parkinsonism Relat Disord       Date:  2019-03-28       Impact factor: 4.891

Review 4.  Is Braak staging valid for all types of Parkinson's disease?

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2018-06-25       Impact factor: 3.575

Review 5.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

Review 6.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

Review 7.  Formation and development of Lewy pathology: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

8.  Lewy body pathology in normal elderly subjects.

Authors:  William R Markesbery; Gregory A Jicha; Huaichen Liu; Frederick A Schmitt
Journal:  J Neuropathol Exp Neurol       Date:  2009-07       Impact factor: 3.685

Review 9.  Dementia in the oldest old.

Authors:  Zixuan Yang; Melissa J Slavin; Perminder S Sachdev
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

10.  Long-term health of dopaminergic neuron transplants in Parkinson's disease patients.

Authors:  Penelope J Hallett; Oliver Cooper; Damaso Sadi; Harold Robertson; Ivar Mendez; Ole Isacson
Journal:  Cell Rep       Date:  2014-06-06       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.